Spruce Biosciences Stock Analysis

Spruce Stock Analysis Notes

About 44.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.31. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Spruce Biosciences recorded a loss per share of 0.95. The entity had not issued any dividends in recent years. Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in Daly City, California. Spruce Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 17 people. To find out more about Spruce Biosciences contact MPH MD at 415 655 4168 or learn more at https://www.sprucebiosciences.com.

Spruce Biosciences Investment Alerts

Spruce Biosciences Upcoming and Recent Events

Spruce Largest EPS Surprises

View All Earnings Estimates

Spruce Stock Institutional Investors

Note, although Spruce Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Spruce Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.07 M.

Spruce Profitablity

Management Efficiency

Spruce Biosciences has return on total asset (ROA) of (0.3035) % which means that it has lost $0.3035 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5755) %, meaning that it created substantial loss on money invested by shareholders. Spruce Biosciences' management efficiency ratios could be used to measure how well Spruce Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of March 3, 2025, Return On Tangible Assets is expected to decline to -0.44. In addition to that, Return On Capital Employed is expected to decline to -0.62. The current year's Other Current Assets is expected to grow to about 7.1 M, whereas Total Assets are forecasted to decline to about 89.5 M.

Technical Drivers

As of the 3rd of March, Spruce Biosciences has the Coefficient Of Variation of (1,646), risk adjusted performance of (0.04), and Variance of 17.51. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Spruce Biosciences, as well as the relationship between them.

Spruce Biosciences Price Movement Analysis

Spruce Biosciences Insider Trading Activities

Spruce Biosciences Outstanding Bonds

Spruce Biosciences Predictive Daily Indicators

Spruce Biosciences Forecast Models

Spruce Biosciences' time-series forecasting models are one of many Spruce Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Spruce Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Spruce Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Spruce shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Spruce Biosciences. By using and applying Spruce Stock analysis, traders can create a robust methodology for identifying Spruce entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Spruce analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Spruce analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Spruce Biosciences stock analysis indicators help investors evaluate how Spruce Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Spruce Biosciences shares will generate the highest return on investment. By understating and applying Spruce Biosciences stock analysis, traders can identify Spruce Biosciences position entry and exit signals to maximize returns.

When running Spruce Biosciences' price analysis, check to measure Spruce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spruce Biosciences is operating at the current time. Most of Spruce Biosciences' value examination focuses on studying past and present price action to predict the probability of Spruce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spruce Biosciences' price. Additionally, you may evaluate how the addition of Spruce Biosciences to your portfolios can decrease your overall portfolio volatility.